|
|
|
04 Sep 2008 |
Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
|
|
04 Sep 2008 |
Nanotherapeutics Files Investigational New Drug Application for NanoDOX(TM) Hydrogel to Treat Lower Extremity Diabetic Ulcers
|
|
04 Sep 2008 |
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
|
|
03 Sep 2008 |
Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
|
03 Sep 2008 |
Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
|
|
03 Sep 2008 |
Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
|
|
03 Sep 2008 |
Plexxikon Initiates Phase 1 Trial for PLX5568
|
|
03 Sep 2008 |
Discovery Labs' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
|
|
03 Sep 2008 |
Discovery Labs' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
|
|
03 Sep 2008 |
Protox completes enrollment of Phase 2 BPH trial
|
|
02 Sep 2008 |
Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
|
|
31 Aug 2008 |
Takeda and Affymax Provide Clinical Development Update for Hematide(TM) in Chemotherapy-induced Anemia
|
|
28 Aug 2008 |
Alseres Pharmaceuticals Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing
|
|
27 Aug 2008 |
NICE final guidance recommends Lucentis(R) as cost-effective treatment for wet AMD, a leading cause of blindness
|
|
26 Aug 2008 |
Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
|
|
25 Aug 2008 |
Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
|
|
25 Aug 2008 |
NicOx provides update on PF-03187207 and the ongoing research collaboration with Pfizer
|
|
21 Aug 2008 |
Kamada Successfully Completes Phase II Trial with Aerosolized AAT in Cystic Fibrosis Patients
|
|
21 Aug 2008 |
Auris Medical reporting results of phase I/II clinical trial with AM-101
|
|
21 Aug 2008 |
PTC124 shows promising activity in Cystic Fibrosis; phase 2 proof-of-concept data published in the lancet
|
|
20 Aug 2008 |
RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial
|
|
20 Aug 2008 |
PregLem starts Phase III trials of PGL4001 in Uterine Myoma
|
|
19 Aug 2008 |
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
|
|
18 Aug 2008 |
Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study and Completion of QT Interval Dose Selection Screen
|
|
16 Aug 2008 |
OrthoLogic Announces Completion of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
|
|
13 Aug 2008 |
Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma
|
|
12 Aug 2008 |
Bronchinol Cystic Fibrosis Dose Trial Results Positive
|
|
12 Aug 2008 |
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
|
|
11 Aug 2008 |
Enrollment in Phase IIb Clinical Trial for I-vation(TM) TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc.
|
|
10 Aug 2008 |
FDA Allows Phase 2 Study for Sound Pharmaceuticals' Novel Drug to Prevent Chemotherapy Induced Hearing Loss
|
|
06 Aug 2008 |
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
|
|
06 Aug 2008 |
Xanodyne Pharmaceuticals, Inc. Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
|
|
05 Aug 2008 |
Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
|
|
03 Aug 2008 |
U.S. FDA Issues Action Letter for Sugammadex
|
|
31 Jul 2008 |
Neuropharma reports last results on its research in Alzheimer’s disease, at the International Conference of Alzheimer’s Disease held in Chicago on July 26-31
|
|
31 Jul 2008 |
Preclinical Data for a Topical Formulation of Voclosporin as a Potential Best-in-Class Treatment for Chronic Inflammatory Eye Diseases Presented at ARVO
|
|
31 Jul 2008 |
Regulatory approval of Basilea’s Toctino(R) (alitretinoin) recommended by concerned EU Member States
|
|
31 Jul 2008 |
Othera Files IND Application for OT-730 in Glaucoma
|
|
31 Jul 2008 |
MediGene Sells Licensee Rights To The Drug Oracea(R) To Galderma
|
|
30 Jul 2008 |
Cytochroma and Mitsubishi Tanabe Form Partnership for Chronic Kidney Disease Therapies in U.S. and Asia
|
|
30 Jul 2008 |
BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
|
|
30 Jul 2008 |
Quark Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in DME
|
|
30 Jul 2008 |
Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of Epodure to Treat Anemia
|
|
29 Jul 2008 |
Inspire Provides Update on Cystic Fibrosis Clinical Program
|
|
29 Jul 2008 |
Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
|
|
29 Jul 2008 |
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
|
|
28 Jul 2008 |
Omrix Biopharmaceuticals Receives Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Evicel(TM) Liquid Fibrin Sealant (Human)
|
|
28 Jul 2008 |
Vyteris Announces Successful Completion of Peptide Dose Ranging Study in Preparation for Phase II Human Clinical Trials
|
|
27 Jul 2008 |
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical Gel as a Treatment for the Common Skin Disease, Impetigo
|
|
26 Jul 2008 |
Sound Pharmaceuticals, Inc. Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
|
| |
|
Results 1 - 50 of 908 |
